1. Home
  2. GOCO vs HOTH Comparison

GOCO vs HOTH Comparison

Compare GOCO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.13

Market Cap

17.7M

Sector

Finance

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.75

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOCO
HOTH
Founded
2001
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
17.7M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
GOCO
HOTH
Price
$1.13
$0.75
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.75
$5.00
AVG Volume (30 Days)
52.3K
3.3M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.69
EPS
N/A
N/A
Revenue
$361,845,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$77.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.49
52 Week High
$9.50
$2.12

Technical Indicators

Market Signals
Indicator
GOCO
HOTH
Relative Strength Index (RSI) 41.91 49.51
Support Level $1.00 $0.49
Resistance Level $1.35 $0.78
Average True Range (ATR) 0.10 0.07
MACD 0.01 0.02
Stochastic Oscillator 40.58 81.30

Price Performance

Historical Comparison
GOCO
HOTH

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions, so it can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. The proprietary technology platform integrates artificial intelligence and modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: